QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist.
about
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in ratsEfficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.Efficacy of olanzapine in symptom relief and quality of life in gastric cancer patients receiving chemotherapy.Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study.Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis.
P2860
QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@en
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@nl
type
label
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@en
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@nl
prefLabel
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@en
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@nl
P2093
P2860
P356
P1476
QoL evaluation of olanzapine f ...... ith 5-HT3 receptor antagonist.
@en
P2093
P2860
P304
P356
10.1111/ECC.12260
P407
P577
2014-11-18T00:00:00Z